First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)

IsraelRecruitingPHASE1, PHASE2

Conditions

Advanced Non-small Cell Lung Cancer · EGFR Mutation · HER2 Mutation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Banner MD Anderson Cancer Center at Banner Gateway Medical Center, Gilbert, Arizona, United States

  • City of Hope - Duarte Cancer Center, Duarte, California, United States

  • Emory Winship Cancer Institute, Atlanta, Georgia, United States

  • The Center for Cancer and Blood Disorders, Bethesda, Maryland, United States

  • Dana-Farber Cancer Institute - Oncology Department, Boston, Massachusetts, United States

  • Brigette Harris Cancer Pavilion at Henry Ford Cancer Center - Detroit, Detroit, Michigan, United States

  • Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States

  • NYU Langone Hospital - Long Island - Urology, Mineola, New York, United States

  • Tennessee Oncology - Nashville Centennial Clinic, Nashville, Tennessee, United States

  • The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston, Texas, United States

  • Virginia Cancer Specialists, PC - Fairfax, Fairfax, Washington, United States

  • UZ Leuven Gasthuisberg - Pneumology Department, Leuven, Flemish Brabant, Belgium

  • AZ Delta | Clinical Trial Center - Pneumology, Roeselare, West Flanders, Belgium

  • Liga Norte Riograndense Contra o Cancer | Centro de Pesquisa Clínica, Natal, Rio Grande do Norte, Brazil

  • Hospital de Base | Integrated Research Center, São José do Rio Preto, São Paulo, Brazil

  • Hospital Israelita Albert Einstein | Morumbi - Clinical Research Department, São Paulo, São Paulo, Brazil

  • Beijing Cancer Hospital - Oncology Department, Beijing, Beijing Municipality, China

  • Beijing Hospital, Beijing, Beijing Municipality, China

  • Fujian Cancer Hospital, Fuzhou, Fujian, China

  • Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China

  • Union Hospi, Tongji Med College, Huazhong Univ. Scien&Tech, Wuhan, Hubei, China

  • Hunan Cancer Hospital - Oncology Department, Changsha, Hunan, China

  • NJ Drum Tower Hospital, the Affil Hos of NJ Univ Med School, Nanjing, Jiangsu, China

  • Zhejiang University School of Medicine - Taizhou Hospital of Zhejiang Province, Taizhou, Jiangsu, China

  • Qilu Hosp., Shandong Univ., Jinan, Shandong, China

  • Shandong University - Shandong Cancer Hospital, Jinan, Shandong, China

  • Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, Shanghai Municipality, China

  • West China Hospital Sichuan University, Chengdu, Sichuan, China

  • Sir Run Run Shaw Hospital, Zhejiang Univ. School of Medicine - Oncology Department, Hangzhou, Zhejiang, China

  • Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

  • UNICANCER - Centre Leon-Berard (CLB) - Medical oncology, Lyon, Auvergne-Rhône-Alpes, France

  • Institut Bergonie - Unicancer Nouvelle Aquitaine - Service Oncologie medicale, Bordeaux, New Aquitaine, France

  • Hopital Nord Laennec - Oncologie medicale thoracique et digestive, Nantes, Pays de la Loire Region, France

  • Institut de Cancerologie Ouest - Saint Herblain - Oncologie medicale, Saint-Herblain, Pays de la Loire Region, France

  • AP-HM - Hopital de la Timone - Centre d'Essais en Cancerologie, Marseille, Provence-Alpes-Côte d'Azur Region, France

  • Institut Curie - Paris - Oncologie medicale, Paris, Île-de-France Region, France

  • Gustave Roussy - Departement Oncologie-Radiotherapie, Villejuif, Île-de-France Region, France

  • Prince of Wales Hospital, Hong Kong, Hong Kong SAR, Hong Kong

  • Queen Mary Hospital, Hong Kong, Hong Kong SAR, Hong Kong

  • Hong Kong United Oncology Centre, Kowloon, Hong Kong

  • Rabin Medical Center | Beilinson Hospital - Nephrology and Hypertension Institute, Petah Tikva, Israel

  • Chaim Sheba Medical Center, Ramat Gan, Israel

  • Istituto Nazionale Tumori IRCCS Fondazione G.Pascale, Naples, Campania, Italy

  • Azienda Ospedaliero Universitaria Parma - SC Oncologia Medica, Parma, Emilia-Romagna, Italy

  • Centro di Riferimento Oncologico di Aviano - Oncologia Medica e dei Tumori Immuno-Correlati, Aviano, Friuli Venezia Giulia, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - UOC Fase I, Rome, Lazio, Italy

  • Fondazione IRCCS Istituto Nazionale dei Tumori - S. C. Oncologia Medica 1, Milan, Lombardy, Italy

  • Istituto Europeo di Oncologia s.r.l - Sviluppo di nuovi farmaci per Terapie Innovative, Milan, Lombardy, Italy

  • Humanitas Mirasole S.p.A. - Oncologia Medica ed Ematologia, Rozzano, Lombardy, Italy

  • Azienda Ospedaliero-Universitaria San Luigi Gonzaga - Oncologia Medica, Orbassano, Piedmont, Italy

  • Centro Ricerche Cliniche Di Verona S.r.l. - Oncologia, Verona, Italy

  • Aichi Cancer Center Hospital, Nagoya, Aichi-ken, Japan

  • National Cancer Center Hospital East, Kashiwa, Chiba, Japan

  • National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan

  • Hokkaido University Hospital, Sapporo, Hokkaido, Japan

  • Kanagawa Cancer Center, Yokohama, Kanagawa, Japan

  • Kindai University Hospital, Sakai, Osaka, Japan

  • Shizuoka Cancer Center, Sunto, Shizuoka, Japan

  • National Cancer Center Hospital, Chuo-ku, Tokyo, Japan

  • Tottori University Hospital, Yonago, Tottori, Japan

  • Okayama University Hospital, Okayama, Japan

  • Osaka International Cancer Institute, Osaka, Japan

  • Radboud University Medical Center | Afdeling Interne Geneeskunde, Nijmegen, Gelderland, Netherlands

  • Nederlands Kanker Instituut, Amsterdam, North Holland, Netherlands

  • Erasmus University Medical Center | Research Department - Lung Diseases, Rotterdam, South Holland, Netherlands

  • Uniwersyteckie Centrum Kliniczne, Gdansk, Poland

  • Uniwersytecki Szpital Kliniczny Nr 2 Uniwersytetu Medycznego w Lodzi, Lodz, Poland

  • START Lisbon, CHULN - Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal

  • Hospital Santa Maria | Centro de Investigacao Clinica, Lisbon, Portugal

  • IPO Porto, Porto, Portugal

  • National University Hospital Medical Centre, Singapore, Singapore

  • National Cancer Center Singapore - Oncology Department, Singapore, Singapore

  • Curie Oncology | Mount Elizabeth Novena, Singapore, Singapore

  • Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea

  • St.Vincent's Hospital, Suwon, Gyeonggi-do, South Korea

  • Chungbuk National University Hospital | Hematology and Oncology, Chungcheongbuk-do, North Chungcheong, South Korea

  • Seoul National University Hospital, Seoul, South Korea

  • Severance Hospital, Yonsei University Health System - Oncology Department, Seoul, South Korea

  • Asan Medical Center | Oncology, Seoul, South Korea

  • Samsung Medical Center - Oncology Department, Seoul, South Korea

  • Institut Catala D'oncologia | Hospitalet | Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain

  • Hospital Universitari Dexeus Grupo Quironsalud | Oncologia, Barcelona, Spain

  • Hospital Universitari Vall D Hebron | Oncologia, Barcelona, Spain

  • Hospital Universitario Fundacion Jimenez Diaz | Oncologia, Madrid, Spain

  • Hospital Universitario Hm Sanchinarro | Oncologia, Madrid, Spain

  • Hospital Universitario Virgen De La Victoria | Oncologia, Málaga, Spain

  • Hospital Universitario Y Politecnico La Fe | Oncologia, Valencia, Spain

  • Chung Shan Medical University Hospital, Taichung, Taiwan

  • Taichung Veterans General Hospital, Taichung, Taiwan

  • National Cheng Kung University Hospital, Tainan, Taiwan

  • Chi-Mei Medical Center, Liouyine, Tainan, Taiwan

  • National Taiwan University Hospital, Taipei, Taiwan

  • Taipei Medical University (TMU) - Shuang Ho Hospital (SHH), Taipei, Taiwan

  • Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan